Discontinued — last reported Q4 '25
Interest Paid
Regeneron Pharmaceuticals Interest Paid remained flat by 0.0% to $10.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 20.9%, from $13.15M to $10.40M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows a downward trend with a -7.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
Detailed definition
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Peer comparison
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paidHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $55.80M | $53.70M | $73.10M | $52.60M | $41.60M |
| YoY Change | — | -3.8% | +36.1% | -28.0% | -20.9% |
Interest Paid at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's interest paid?
- Regeneron Pharmaceuticals (REGN) reported interest paid of $10.40M in Q4 2025.
- How has Regeneron Pharmaceuticals's interest paid changed year-over-year?
- Regeneron Pharmaceuticals's interest paid decreased by 20.9% year-over-year, from $13.15M to $10.40M.
- What is the long-term trend for Regeneron Pharmaceuticals's interest paid?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's interest paid has grown at a -7.1% compound annual growth rate (CAGR), from $55.80M to $41.60M.
- What does interest paid mean?
- The actual cash paid to lenders for interest on debt.